Analysis of skeletal-related events in breast cancer and response to therapy

被引：26

作者：

LoRusso, P ^{[1
]}

机构：

[1] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 04期

关键词：

D O I：

10.1016/S0093-7754(01)90228-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：22 / 27

页数：6

共 15 条

[1]

Berenson JR, 2001, CANCER, V91, P1191, DOI 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO

[2]

2-0

[3] Current use of bisphosphonates in oncology [J].

Body, JJ ;

Bartl, R ;

Burckhardt, P ;

Delmas, PD ;

Diel, IJ ;

Fleisch, H ;

Kanis, JA ;

Kyle, RA ;

Mundy, GR ;

Paterson, AHG ;

Rubens, RD .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) :3890-3899

[4]

Coleman RE, 1998, REV CONTEMP PHARMACO, V9, P147

[5]

COLEMAN RE, 1998, CANCER S8, V80, P1588

[6]

Demers Laurence M., 2000, Cancer, V88, P2919, DOI 10.1002/1097-0142(20000615)88:12+<2919::AID-CNCR7>3.0.CO

[7]

2-Z

[8]

GREEN JR, 1994, J BONE MINER RES, V9, P745

[9] Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate [J].

Hortobagyi, GN ;

Theriault, RL ;

Lipton, A ;

Porter, L ;

Blayney, D ;

Sinoff, C ;

Wheeler, H ;

Simeone, JF ;

Seaman, JJ ;

Knight, RD ;

Heffernan, M ;

Mellars, K ;

Reitsma, DJ .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2038-2044

[10] Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases [J].